Tocilizumab and liver injury in patients with COVID-19

Current mortality rate in patients with COVID-19 disease is about 2%, whereas 5% of patients require admission to the intensive care unit. It is assumed that interleukin (IL)-6 may be involved in the pathogenesis of severe COVID-19 infections; therefore, in the absence of a specific antiviral therap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therap Adv Gastroenterol
Hauptverfasser: Serviddio, Gaetano, Villani, Rosanna, Stallone, Giovanni, Scioscia, Giulia, Foschino-Barbaro, Maria Pia, Lacedonia, Donato
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2020
Schlagworte:
Case Series
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545299/
https://ncbi.nlm.nih.gov/pubmed/33101458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820959183
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge